300777SZSE

2025 Annual Report of Independent Director (Xu Gaoyan)

✨ AI Summary

This report outlines Xu Gaoyan's performance as an independent director of Zhongjian Technology Co., Ltd. in 2025. Key activities included attending all board and shareholder meetings, participating in various committees, and overseeing significant transactions. The report confirms compliance with legal requirements and emphasizes the protection of shareholder interests, particularly for minority shareholders.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

1. Basic Information

I, Xu Gaoyan, born in 1983, hold a Ph.D. in Accounting from Nanjing University and am a professor at Hohai University. I am a Chinese national with no permanent residency abroad and a member of the Communist Party of China. Currently, I serve as an independent director of the company, as well as independent director for Inner Mongolia Shengshi Chemical Co., Ltd. and Yangzhou Chenhua New Materials Co., Ltd. During the reporting period, I did not hold any position other than independent director and have no direct or indirect interests with the company or its major shareholders that could affect my independent judgment.

2. Performance in 2025

After assuming my role, I actively participated in all board and shareholder meetings, diligently reviewing proposals and related materials, engaging in discussions, and providing reasonable suggestions to facilitate correct and scientific decision-making by the board. In 2025, the convening of board and shareholder meetings complied with legal procedures, and all significant operational decisions followed the necessary approval processes. My attendance at meetings is as follows:

(1) Attendance at Shareholder Meetings

In 2025, the company held 5 shareholder meetings, all of which I attended.

(2) Attendance at Board Meetings

In 2025, the company held 12 board meetings, all of which I personally attended and voted in favor of all proposals discussed, with 4 attended in person and 8 via telecommunication. I did not authorize any other independent directors to attend meetings on my behalf and raised no objections to any company matters.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.